• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淀粉样心肌病中的地高辛敏感性。

Digoxin sensitivity in amyloid cardiomyopathy.

作者信息

Rubinow A, Skinner M, Cohen A S

出版信息

Circulation. 1981 Jun;63(6):1285-8. doi: 10.1161/01.cir.63.6.1285.

DOI:10.1161/01.cir.63.6.1285
PMID:7014028
Abstract

Digoxin (5 mg/ml) was added to 10-mg and 20-mg pellets of purified primary and secondary amyloid fibrils, a normal human liver and heart homogenate and a homogenate from the heart of a patient with amyloid cardiomyopathy who had not received digitalis. After centrifugation, the supernatants were recovered and assayed for digoxin concentrations. Aliquots from the sediments were studied for the presence of digoxin, using rabbits antidigoxin antiserum and an indirect immunofluorescent technique. The results showed that 0.11--0.13 ng/ml of digoxin bound per milligram of fibrils and could not be separated by repeated washings. Elution with citrate or changes in the pH of the buffer. Immunofluorescent studies demonstrated diffusely bright immunofluorescence with the fibril preparation and amyloid heart homogenate when reacted with digoxin and digoxin-specific antiserum. These studies demonstrate that isolated amyloid fibrils bind digoxin and suggest that this interaction may play some role in the sensitivity to digitalis that has been observed in some patients with amyloid cardiomyopathy.

摘要

将地高辛(5毫克/毫升)添加到纯化的原发性和继发性淀粉样原纤维的10毫克和20毫克丸剂、正常人肝脏和心脏匀浆以及一名未接受洋地黄治疗的淀粉样心肌病患者的心脏匀浆中。离心后,回收上清液并测定地高辛浓度。使用兔抗地高辛抗血清和间接免疫荧光技术研究沉淀物的等分试样中是否存在地高辛。结果表明,每毫克原纤维结合0.11--0.13纳克/毫升地高辛,且经反复洗涤无法分离。用柠檬酸盐洗脱或改变缓冲液的pH值。免疫荧光研究表明,当与地高辛和地高辛特异性抗血清反应时,原纤维制剂和淀粉样心脏匀浆呈现弥漫性明亮的免疫荧光。这些研究表明,分离出的淀粉样原纤维结合地高辛,并提示这种相互作用可能在一些淀粉样心肌病患者中观察到的对洋地黄的敏感性中起某种作用。

相似文献

1
Digoxin sensitivity in amyloid cardiomyopathy.淀粉样心肌病中的地高辛敏感性。
Circulation. 1981 Jun;63(6):1285-8. doi: 10.1161/01.cir.63.6.1285.
2
Reversal of digitalis effects by specific antibodies.
Pharmacology. 1979;18(1):1-8. doi: 10.1159/000137223.
3
Senile cardiac amyloid: evidence that fibrils contain a protein immunologically related to prealbumin.老年心脏淀粉样变:原纤维含有与前白蛋白免疫相关蛋白质的证据。
Immunology. 1981 Nov;44(3):447-52.
4
The isolation of digoxin-specific antibody and its use in reversing the effects of digoxin.地高辛特异性抗体的分离及其在逆转地高辛作用方面的应用。
Proc Natl Acad Sci U S A. 1971 Oct;68(10):2401-6. doi: 10.1073/pnas.68.10.2401.
5
Suitability of antidigoxin antiserum for digoxin in plant extracts.抗地高辛抗血清对植物提取物中地高辛的适用性。
Lloydia. 1977 May-Jun;40(3):231-5.
6
Senile cardiac amyloid: demonstration of a unique fibril protein in tissue sections.老年心脏淀粉样变:组织切片中一种独特纤维蛋白的显示
J Immunol. 1978 Apr;120(4):1385-8.
7
Antibodies of restricted heterogeneity directed against the cardiac glycoside digoxin.针对强心苷地高辛的具有有限异质性的抗体。
J Immunol. 1978 Jul;121(1):122-9.
8
The amyloid in familial amyloid cardiomyopathy of Danish origin is related to pre-albumin.源于丹麦的家族性淀粉样心肌病中的淀粉样蛋白与前白蛋白有关。
Clin Exp Immunol. 1985 Apr;60(1):207-16.
9
Effect of anti-digoxin antiserum on endoxin and membrane ATPase activity in hypoxia-reoxygenation induced myocardial injury.抗地高辛抗血清对缺氧复氧诱导的心肌损伤中内毒素及膜ATP酶活性的影响
Acta Pharmacol Sin. 2000 Apr;21(4):345-7.
10
Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition.遗传性转甲状腺素蛋白V30M淀粉样变性中的淀粉样心肌病——性别和淀粉样纤维成分的影响
PLoS One. 2015 Nov 23;10(11):e0143456. doi: 10.1371/journal.pone.0143456. eCollection 2015.

引用本文的文献

1
Heart Failure Management in Cardiac Amyloidosis: Towards a Paradigm Shift.心脏淀粉样变中的心力衰竭管理:迈向范式转变。
Card Fail Rev. 2025 Jul 17;11:e15. doi: 10.15420/cfr.2024.33. eCollection 2025.
2
Digoxin toxicity with therapeutic serum digoxin concentrations.治疗性血清地高辛浓度下的地高辛毒性
Toxicol Rep. 2025 Jul 5;15:102079. doi: 10.1016/j.toxrep.2025.102079. eCollection 2025 Dec.
3
His108Arg Transthyretin Amyloidosis-Shedding Light on a Distinctively Malignant Variant.His108Arg转甲状腺素蛋白淀粉样变性——揭示一种独特的恶性变体
J Clin Med. 2024 Dec 23;13(24):7857. doi: 10.3390/jcm13247857.
4
Disease-modifying therapies for amyloid transthyretin cardiomyopathy: Current and emerging medications.转甲状腺素蛋白淀粉样变心肌病的疾病修饰疗法:现有及新兴药物
Pharmacotherapy. 2025 Feb;45(2):124-144. doi: 10.1002/phar.4639. Epub 2024 Dec 23.
5
Diagnostic and therapeutic challenges in rapidly progressing cardiac amyloidosis: a literature review based on case report.快速进展性心脏淀粉样变性的诊断与治疗挑战:基于病例报告的文献综述
Int J Emerg Med. 2024 Oct 21;17(1):159. doi: 10.1186/s12245-024-00750-x.
6
Emerging from the Darkness. Sudden Cardiac Death in Cardiac Amyloidosis.走出黑暗。心脏淀粉样变性中的心脏性猝死。
Rev Cardiovasc Med. 2022 Oct 14;23(10):345. doi: 10.31083/j.rcm2310345. eCollection 2022 Oct.
7
Arrhythmic Risk Stratification in Cardiac Amyloidosis: A Review of the Current Literature.心脏淀粉样变性中的心律失常风险分层:当前文献综述
J Cardiovasc Dev Dis. 2024 Jul 14;11(7):222. doi: 10.3390/jcdd11070222.
8
[Arrhythmias and amyloidosis].[心律失常与淀粉样变性]
Herzschrittmacherther Elektrophysiol. 2024 Sep;35(3):199-204. doi: 10.1007/s00399-024-01016-y. Epub 2024 May 13.
9
Arrhythmias and Device Therapies in Cardiac Amyloidosis.心脏淀粉样变性中的心律失常与器械治疗
J Clin Med. 2024 Feb 25;13(5):1300. doi: 10.3390/jcm13051300.
10
Coronary artery bypass grafting for triple vessel disease in cardiac amyloidosis.心脏淀粉样变性的三血管病变行冠状动脉旁路移植术。
BMJ Case Rep. 2023 Sep 12;16(9):e254668. doi: 10.1136/bcr-2023-254668.